跳至主要内容
临床试验/KCT0007037
KCT0007037已完成未知

The Efficacy of Soluble Microneedle Drug Delivery System Combined for Ameliorating Dry Skin in Atopic Dermatitis: A Control Group (Normal Patch)-used, Investigator-initiated, Assessor-blinded, Randomized Controlled Parallel Trial

aju Dongshin University Korean Medicine Hospital0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19?(Year) 至 60?(Year)(—)
性别
All

入选标准

  • Participants should meet all of the following criteria;
  • (1) Male and female patients aged 19-60 at the screening visit.
  • (2) Atopic dermatitis patients diagnosed by Hanifin and Rajka criteria and have dry skin. Atopic dermatitis can be diagnosed if the patient has more than 3 of 4 major symptoms and 3 of 23 minor symptoms in the Hanifin and Rajka criteria.
  • (3) Patients who have 2 similar dry skin lesions in order to compare the efficacy of biodegradable microneedle patch with normal patch.
  • (4) Patients who submitted written consent voluntarily.

排除标准

  • The patient who meets any of the following criteria cannot participate in;
  • (1) Patients who were taking intensive medication such as antihistamines or steroids.
  • (2) Patients who used oral antihistamines, oral antibiotics, oral or topical steroids, systemic photochemotherapy, or other immunosuppressants within 4 weeks before this study begins.
  • (3) Patients having systemic infection or taking systemic antibiotic therapy.
  • (4) Patients having other severe skin diseases, except atopic dermatitis.
  • (5) Patients taking interferon medication, including interferon-alpha and interferon-beta.
  • (6) Liver patients, including cirrhosis or liver cancer.
  • (7) Kidney patients, including acute/chronic renal failure, or nephrotic syndrome.
  • (8) Severe acute cardiovascular patients including heart failure, myocardial infarction, or stroke.
  • (9) Patients who took antipsychotics within 3 months before screening.
  • (10) Patient who are sensitive to natural products.
  • (11) Patients who have an allergy to adhesives.
  • (12) Pregnant or nursing women.
  • (13) Severe oozing or maceration.
  • (14) Others who principal investigator decided inadequate.

研究者

发起方
aju Dongshin University Korean Medicine Hospital

相似试验